DE3650368D1 - Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf. - Google Patents

Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.

Info

Publication number
DE3650368D1
DE3650368D1 DE3650368T DE3650368T DE3650368D1 DE 3650368 D1 DE3650368 D1 DE 3650368D1 DE 3650368 T DE3650368 T DE 3650368T DE 3650368 T DE3650368 T DE 3650368T DE 3650368 D1 DE3650368 D1 DE 3650368D1
Authority
DE
Germany
Prior art keywords
depogen
blood circulation
diethoxy
restricted blood
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3650368T
Other languages
English (en)
Other versions
DE3650368T2 (de
Inventor
Peter Szentmiklosi
Istvan Hermecz
Zoltan Meszaros
Laszlo Tardos
Jeno Marton
Lelle Vasvari
Agnes Horvarth
Katalin Marmarosi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of DE3650368D1 publication Critical patent/DE3650368D1/de
Application granted granted Critical
Publication of DE3650368T2 publication Critical patent/DE3650368T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE3650368T 1985-12-04 1986-12-04 Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf. Expired - Fee Related DE3650368T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU854639A HU197207B (en) 1985-12-04 1985-12-04 Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient

Publications (2)

Publication Number Publication Date
DE3650368D1 true DE3650368D1 (de) 1995-09-21
DE3650368T2 DE3650368T2 (de) 1996-01-18

Family

ID=10968537

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3650368T Expired - Fee Related DE3650368T2 (de) 1985-12-04 1986-12-04 Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.

Country Status (6)

Country Link
US (1) US4814336A (de)
EP (1) EP0227356B1 (de)
JP (1) JPH0655672B2 (de)
AT (1) ATE126437T1 (de)
DE (1) DE3650368T2 (de)
HU (1) HU197207B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT60926A (en) * 1991-04-12 1992-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability
HUT68560A (en) * 1993-08-02 1995-04-27 Chinoin Gyogyszer Es Vegyeszet The use of xantine derivatives for promotion of healing of operative lesions
JP3276762B2 (ja) * 1993-12-28 2002-04-22 日本臓器製薬株式会社 イソキノリン誘導体を含有する医薬組成物
ES2545962T3 (es) * 2008-11-27 2015-09-17 Lidds Ab Uso de carboximetilcelulosa para controlar la capacidad de eyección y el tiempo de solidificación de composiciones que comprenden una o más cerámicas biorreabsorbibles
HUE038538T2 (hu) * 2011-05-20 2018-10-29 Chinoin Private Co Ltd Drotaverint tartalmazó gyógyszerészeti készítmény

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1129134A (en) * 1964-11-04 1968-10-02 Sterling Winthrop Group Ltd Improvements in compositions containing nicotinates
FR4135M (de) * 1965-01-19 1966-05-02
DE1492203A1 (de) * 1965-12-29 1970-01-15 Thomae Gmbh Dr K Verfahren zur Herstellung von stabilen Loesungen des Theophyllins
FR2181717B1 (de) * 1968-11-25 1976-11-05 Albert Ag Chem Werke
FR2202686A1 (en) * 1972-10-13 1974-05-10 Fabre Sa Pierre Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia
HU167246B (de) * 1973-01-25 1975-09-27
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4383997A (en) * 1980-11-26 1983-05-17 Boucher John H Method of treating horses to inhibit or reduce increases in crenated red blood cells during exercise

Also Published As

Publication number Publication date
JPH0655672B2 (ja) 1994-07-27
JPS62187411A (ja) 1987-08-15
DE3650368T2 (de) 1996-01-18
HUT42940A (en) 1987-09-28
US4814336A (en) 1989-03-21
HU197207B (en) 1989-03-28
ATE126437T1 (de) 1995-09-15
EP0227356A3 (en) 1989-12-13
EP0227356B1 (de) 1995-08-16
EP0227356A2 (de) 1987-07-01

Similar Documents

Publication Publication Date Title
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DK179286D0 (da) Insulinpraeparat
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
ES2000428T3 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
ATE65505T1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
DE68909409T2 (de) Heilmitteldosierung zur verabreichung an fische.
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
DK47089D0 (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
DE3685853T2 (de) Mittel zur behandlung von knochenkrankheiten.
ATE80039T1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DK0499679T3 (da) Terapeutisk middel til diabetisk gangræn
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
GR3006147T3 (de)
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
RO94684A2 (ro) Medicament pentru tratamentul unor dermatoze
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee